US Bancorp
PRME icon

US Bancorp’s Prime Medicine PRME Stock Holding History

US Bancorp’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33
Closed -$115 – 4310
2026
Q1 		$115 Buy
+33
New +$126 ﹤0.01% 4125
2025
Q1 		– Sell
-202
Closed -$590 – 4328
2024
Q4 		$590 Buy
+202
New +$709 ﹤0.01% 4013
2023
Q4 		– Sell
-346
Closed -$3.3K – 4111
2023
Q3 		$3.3K Hold
346
– – ﹤0.01% 3553
2023
Q2 		$5.07K Buy
+346
New +$4.83K ﹤0.01% 3473

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

US Bancorp's PRME Position: Q2 2026 in Review

US Bancorp sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 33 shares — an estimated $115 sold.

US Bancorp first reported a position in PRME in Q2 2023 and held it in 4 quarters. The position peaked at $5.07K in Q2 2023. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • US Bancorp reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 33 Prime Medicine shares in Q2 2026, an estimated $115.
  • US Bancorp first reported a position in Prime Medicine in Q2 2023 and held it in 4 quarters.
  • US Bancorp's Prime Medicine position peaked at $5.07K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.